Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Financiere de TubizeLTS:0D53 +0.29%43 9-Day RSI is 23.44 as of Jul. 19, 2026. GuruFocus rates LTS:0D53 with a GF Score™ of 43/100. The stock has 1 warning sign investors should review. Among 1,423 Biotechnology companies, Financiere de Tubize ranks better than 75.05% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Financiere de Tubize's 9-Day RSI or its related term are showing as below:
LTS:0D53's 9-Day RSI is ranked better than 75.05% of 1423
companies
in the Biotechnology industry
Industry Median: 44.39
vs LTS:0D53: 23.44
Financiere de Tubize (LTS:0D53) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Financiere de Tubize 9-Day RSI Related Terms
LTS:0D53 vs VRTX, REGN, ALNY: 9-Day RSI Comparison
For the Biotechnology subindustry, Financiere de Tubize's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Financiere de Tubize 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Financiere de Tubize's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Financiere de Tubize's 9-Day RSI falls into.
Financiere de Tubize (LTS:0D53) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Financiere de Tubize (LTS:0D53) has a 9-Day RSI of 23.44 as of Jul. 19, 2026. According to the industry distribution chart, Financiere de Tubize ranks #355 out of 1423 companies in the Biotechnology industry, placing it in the top 24.9%.
Is Financiere de Tubize's 9-Day RSI too high?
Financiere de Tubize's current 9-Day RSI is 23.44. The Biotechnology industry median 9-Day RSI is 44.39. Financiere de Tubize's value of 23.44 is 47.2% below this industry median. Based on the distribution chart, Financiere de Tubize ranks #355 out of 1423 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Financiere de Tubize has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's 9-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Financiere de Tubize ranks #355 out of 1423 companies for 9-Day RSI. This places Financiere de Tubize in the top 25% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 44.39. Financiere de Tubize's value of 23.44 is 47.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 44.39, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Financiere de Tubize's current 9-Day RSI of 23.44 is 47.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 44.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Financiere de Tubize's current 9-Day RSI is 23.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (LTS:0D53) has a current 9-Day RSI of 23.44. The current 9-Day RSI is 23.44 and 47.2% below the Biotechnology industry median of 44.39. Financiere de Tubize's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Financiere de Tubize (LTS:0D53), the current 9-Day RSI is 23.44 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
43GF Score
Get the complete analysis for LTS:0D53
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0D53 has been successfully added to your 
